I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| macrophage | 9 studies | 22% ± 4% | |
| non-classical monocyte | 6 studies | 22% ± 3% | |
| epithelial cell | 6 studies | 34% ± 18% | |
| classical monocyte | 5 studies | 22% ± 3% | |
| endothelial cell | 5 studies | 19% ± 2% | |
| basal cell | 5 studies | 27% ± 9% | |
| leukocyte | 4 studies | 17% ± 1% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 18% ± 3% | |
| ciliated cell | 4 studies | 28% ± 13% | |
| dendritic cell | 4 studies | 22% ± 5% | |
| monocyte | 4 studies | 22% ± 5% | |
| microglial cell | 4 studies | 23% ± 6% | |
| hematopoietic precursor cell | 3 studies | 17% ± 2% | |
| myeloid cell | 3 studies | 24% ± 3% | |
| lymphocyte | 3 studies | 22% ± 4% | |
| secretory cell | 3 studies | 28% ± 3% | |
| astrocyte | 3 studies | 17% ± 1% |
